Comparing Adalimumab vs Vedolizumab

View side-by-side comparisons of medication uses, ratings, cost, side effects and interactions.
Adalimumab	Vedolizumab	Enter another drug to compare

Adalimumab

Vedolizumab

Prescription only

Adalimumab is a TNF-alfa inhibitor that may be used to treat a wide range of different inflammatory conditions, such as rheumatoid Arthritis, psoriasis, ankylosing spondylitis, Crohn's disease, and... View more

Prescription only

Prescribed for Crohn's Disease - Maintenance, Ulcerative Colitis, Crohn's Disease. Vedolizumab may also be used for purposes not listed in this medication guide.

More about Adalimumab

More about Vedolizumab

Ratings & Reviews

Adalimumab has an average rating of 6.4 out of 10 from a total of 743 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 30% reported a negative effect.

Vedolizumab has an average rating of 6.3 out of 10 from a total of 187 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 27% reported a negative effect.

View all 743 reviews

View all 187 reviews

Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified.

Pain (10.8%)
Headaches (4.6%)
Psoriasis (4.3%)
Rash (4.3%)
Fatigue (4.2%)
Tiredness (3.6%)
Swelling (3.2%)

View all Adalimumab side effects

Fatigue (15.5%)
Joint pain (12.8%)
Hair loss (9.1%)
Headaches (8.6%)
Tiredness (8.6%)
Pain (5.9%)
Diarrhea (4.8%)

View all Vedolizumab side effects

Drug Class

Selective immunosuppressants

Generic Availability

Lower cost generic

N/A

Pricing and Coupons * Prices are without insurance

Quantity	2 kit
Strength	adbm 40 mg/0.4 mL
Per unit^*	$707.06 - $2,006.60
Cost^*	$1,414.11 - $4,013.20

View all Adalimumab prices

We could not find an exact match for this medicine. Try searching the Price Guide directly.

Get free Discount Card

Dosage Forms

Subcutaneous kit
Subcutaneous solution

N/A

Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value.

480 hours

600 hours

CSA Schedule ¹ View glossary of CSA terms

Not a controlled drug

Is not subject to the Controlled Substances Act.

Not a controlled drug

Is not subject to the Controlled Substances Act.

Pregnancy Category

Category B No proven risk in humans

See the full pregnancy warnings document.

Category B No proven risk in humans

See the full pregnancy warnings document.

Drug Interactions

A total of 553 drugs are known to interact with Adalimumab:

300 major drug interactions (870 brand and generic names)
244 moderate drug interactions (942 brand and generic names)
9 minor drug interactions (37 brand and generic names)

A total of 168 drugs are known to interact with Vedolizumab:

44 major drug interactions (118 brand and generic names)
115 moderate drug interactions (325 brand and generic names)
9 minor drug interactions (37 brand and generic names)

Alcohol/Food/Lifestyle Interactions

No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider.

Disease Interactions

First Approval Date

N/A

May 20, 2014

WADA Class View classifications

N/A

More Information

Patient Resources

Vedolizumab uses

Professional Resources

¹ The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Comparing Adalimumab vs Vedolizumab

See also:

Humira

Cosentyx

Ilumya

Entyvio

Otezla

Skyrizi

Omvoh

Stelara

Taltz

Vtama

Further information

Comparing Adalimumab vs Vedolizumab

See also:

Further information

Compare Drugs